20.648 articles found

α-Synuclein targeted therapy with multiple pathological improvement for Parkinson's disease by macrocyclic amphiphile nanomedicine

Gao JM, Li WB, Yi Y, Wei JJ, Gong MX, Pan BB, Su XC, Pan YC, Guo DS, Gong QH.

Biomaterials · 2025-11-01

A <i>meta</i>-analysis of the long-term efficacy of Amantadine for Levodopa-induced dyskinesia in Parkinson's disease.

Williams K, Curtis MA, Gombinsky L, Parmar P.

Clin Park Relat Disord · 2025-11-01

DOI: 10.1016/j.prdoa.2025.100405PMID: 41281192

Combined Extracorporeal Carbon Dioxide Removal (ECCO2R) With Renal Replacement Therapy and Blood Purification in a Severe Inhalation Injury Patient-Case Report.

Nunes RS, Iazzetta KDG, Lins PRG, Rizzo ML, Vieira IM, Silva VB, Alkmin GCT, Cipriano FEG, Misiara GP, Neto OMV.

J Burn Care Res · 2025-11-01

DOI: 10.1093/jbcr/iraf128PMID: 40673820

Methylene Blue Attenuates 3-Nitropropionic Acid-Induced Oxidative Stress and Mitochondrial Dysfunction in Striatal Cells: Therapeutic Implications in Huntington's Disease Neuropathology.

Hale HK, Elias KM, Ho S, Kwakye GF.

Int J Mol Sci · 2025-11-01

DOI: 10.3390/ijms262110672PMID: 41226707

Genome-Wide Meta-Analysis of Parkinson's Disease Associated Genetic Loci and Validation of Therapeutic Targets.

Yang S, Wu Q, Yang X.

Brain Behav · 2025-11-01

DOI: 10.1002/brb3.71087PMID: 41251092

"YiJinJing, Wohu Pushi" Posture-Voice Therapy for Dysarthria in Parkinson's Disease Patients Following Subthalamic Nucleus Deep Brain Stimulation: A Randomized Controlled Trial.

Yang M, Sun X, Yan J, Zeng Z, Tan Y, Yan S, Wang Y, Wang L, Niu CM, Li D.

CNS Neurosci Ther · 2025-11-01

DOI: 10.1111/cns.70652PMID: 41254931

AMPK/SIRT1/PGC-1α Signaling Pathway: Molecular Mechanisms and Targeted Strategies From Energy Homeostasis Regulation to Disease Therapy.

Chen J, Liu B, Yao X, Yang X, Sun J, Yi J, Xue F, Zhang J, Shen Y, Chen B, Sun H.

CNS Neurosci Ther · 2025-11-01

DOI: 10.1111/cns.70657PMID: 41268687

Single-Cell Transcriptomics Uncovers Cellular Heterogeneity, Mechanisms, and Therapeutic Targets for Ferroptosis-Related Genes in Parkinson's Disease.

Liu M, Yang M, Guo K, Zhu S, Yang J.

Eur J Neurosci · 2025-11-01

DOI: 10.1111/ejn.70339PMID: 41276944

[The application of Lee Silverman voice treatment in Parkinson's disease].

Vastag-Gyulyás R, Bóna J, Jakab K, Klivényi P.

Ideggyogy Sz · 2025-11-01

DOI: 10.18071/isz.78.0425PMID: 41324538

[Short-to-medium-term clinical efficacy of total hip arthroplasty with Pinnacle ES constrained liner in the treatment of femoral neck fractures associated with lower limb neuromuscular disorders].

Wang CF, Wang XQ, Han L, Hu YG, Wang T.

Zhongguo Gu Shang · 2025-11-01

DOI: 10.12200/j.issn.1003-0034.20250712PMID: 41340305

Cortical Sulcal Depth Alterations in Parkinson's Disease Patients With Levodopa-Induced Dyskinesia.

Si Q, Gan C, Shi J, Yu S, Cao X, Sun H, Wang X, Wang X, Wang G, Yuan Y, Zhang K.

J Integr Neurosci · 2025-11-01

DOI: 10.31083/jin45203PMID: 41351441

The Endocannabinoid System: Pharmacological Targets and Therapeutic Potential in CNS Disorders.

Al-Eitan LN, ElSharkawy MT, Alahmad SZ, Khair IY, Mihyar AH, Almahdawi DL.

Curr Neuropharmacol · 2025-10-31

DOI: 10.2174/011570159x404678251021091920PMID: 41178765